Dystrogen Gene Therapiessp. z o.o.
Research and experimental development on biotechnology
KRS: NIP: REGON:
Overview
Status
Active
Registry date
2019-08-14
Share capital
5,000.00 PLN
Registered address
ul. Władysława Pytlasińskiego 10/12/14, 00-777 Warszawa, Poland
Electronic delivery address
AE:PL-62810-66161-TEVDT-24
Financials
Revenue history (in k)
Filing timeliness
No financial statement for 2022 – the filing deadline has passed. 2 of 2 financial statements were filed late (the longest delay 794 days for 2020).
- 2022not filed
- 202118/12/2023
- 202018/12/2023
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2021.
Voivodeship · Mazowieckie101,399 / 142,033
Top 71%
Country · Poland362,855 / 495,860
Top 73%
Results vs industry
Revenue
This companyUSD 32.71kMedianUSD 55.24kAverageUSD 2.70m
Net profit
This companyUSD 2.04kMedianUSD -1.27kAverageUSD -92.18k
Operating costs
This companyUSD 25.25kMedianUSD 65.85kAverageUSD 2.66m
Assets
This companyUSD 27.41kMedianUSD 133.19kAverageUSD 3.03m
Industry
Authorized Representatives
Filip Jan Jeleń – President of the Management Board
Manner of representation
Each member of the management board is authorised to represent the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Dystrogen Gene Therapies Inc. | 100 | $1,350.62 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2019-10-07.
83 1090 1870 0000 0001 4308 0701
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Apr 1, 2020 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | –– | Fundacja Innowacyjna Polska | |
| Apr 1, 2020 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | –– | BTM Innovations sp. z o.o. |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| ModicaP.S.A. | $103,400.72 | modica.bio | ||
| AI Corelabsp. z o.o. | $106,857.00 | aicorelab.com | ||
| WPD PharmaceuticalsS.A. | $87,561.70 | wpdpharmaceuticals.pl | ||
| Zawamedsp. z o.o. | $43,909.06 | zawamed.pl | ||
| Orphinic ScientificS.A. | $42,972.42 | orphinic.com | ||
| Stenocoatsp. z o.o. | $36,665.21 | stenocoat.com | ||
| Immbionicsp. z o.o. | $31,756.23 | immbionic.com.pl | ||
| Platforma Badań Genetycznychsp. z o.o. | $28,558.39 | zdrowegeny.pl | ||
| Medtransfersp. z o.o. | $21,666.01 | codete.com | ||
| Bioselsp. z o.o. | $19,100.32 | selol.pl |
FAQ
Last updated: 2026-10-03